Concepedia

Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serum

Sheng Yü, Zhenfeng Li, Jingzhang Li, Shimei Zhao, Shanguang Wu, Hongjing Liu, Xiongjie Bi, Dongyang Li, Jie-Xian Dong, Siliang Duan,

Sensors and Actuators B Chemical · 2021 · 39 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

, , +16

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

Mariana Capurro, Ian R. Wanless, Morris Sherman et al. · Gastroenterology · 2003 · 907 citations · Full text

, , +16

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker

Tetsuya Nakatsura, Yoshihiro Yoshitake, Satoru Senju et al. · Biochemical and Biophysical Research Communications · 2003 · 432 citations

, , +14

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe et al. · Cancer Research · 2004 · 297 citations · Full text

, , +17

First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma

Andrew X. Zhu, Philip J. Gold, Anthony B. El-Khoueiry et al. · Clinical Cancer Research · 2013 · 194 citations · Full text

, , +14